Idiopathic Pulmonary Fibrosis Animation
Scientific Animation | Investor Relations & Website Assets
Created for Endeavor Biomedicines, this medical animation focuses on how their specific hedgehog inhibitor has the potential to improve lung function and reverse the fibrotic process in the lungs of individuals with Idiopathic Pulmonary Fibrosis (IPF).
Endeavor’s investigational candidate is a hedgehog signaling pathway inhibitor. By binding to and inhibiting a key receptor in the hedgehog pathway, it aims to reduce the abnormal accumulation of myofibroblasts, which are associated with fibrosis. This approach may help to address the excessive wound-healing process observed in IPF (Idiopathic Pulmonary Fibrosis), with the potential to influence fibrosis and support lung volume and function.
Designed for a diverse audience, including investors, Key Opinion Leaders (KOLs), and patients, the animation visually presents aspects of the hedgehog pathway, drawing on Endeavor’s clinical results. Strategically placed on the company’s ‘Our Science’ page, the animation serves as an educational tool, developed to help communicate information about this novel treatment.
Are you interested in seeing how our scientific animation can help you?
Related work
